γδ T-cells constitutively express RORγt and its target IL-23 receptor [34], thus therapeutic targeting of RORγt-dependent responses elicited by these cells may be beneficial in the treatment of autoimmune diseases, such as psoriasis or of the acute stages of multiple sclerosis [35, 36]. The gene discussed is IL23R; the disease is multiple sclerosis.